Clear thinking on mind and body, for the UK
NHS Talking Therapies is often described as help for 'mild to moderate' anxiety and depression, but that phrase conceals clinical scores, service thresholds and local judgements. This explainer unpacks how measures such as the PHQ-9 and GAD-7 shape access, what happens when someone is judged too complex or not unwell enough, and the questions patients can reasonably ask.
Group CBT is often offered as a routine NHS treatment, yet few patients are told what the sessions actually involve. This explainer sets out the structure, the homework, the limits and the questions worth asking before accepting a place.
A private ADHD assessment is often the easy part. The harder negotiation comes afterwards, when a GP practice is asked to take on prescribing under a shared care agreement. Here are the five questions worth settling before any money changes hands.
Probiotic supplements increasingly borrow the language of neuroscience, promising calmer minds via the gut-brain axis. The biology is real; the marketing often outruns it. A practical guide to separating the two.
Anxiety and depression are real conditions, and most diagnoses of them are correct. But a handful of physical illnesses — thyroid disease, anaemia, sleep apnoea, perimenopause, diabetes — produce symptoms that look almost identical, and a label applied too early can close the door on them. A measured guide to which checks have evidence behind them, and how to ask for them well.
The community pharmacy is the most frequently visited front door in the NHS, yet few people think to use it for anything connected to mood, sleep or medication worry. Here are seven things a pharmacist can usefully do — and a clear account of the point at which the counter stops and the GP surgery begins.
A GP appointment about aching joints and low mood can end with a referral not to physiotherapy but to a gardening group on the edge of town. Drawing on an interview with a link worker in Greater Manchester and a clear-eyed reading of the evidence, this feature explains what social prescribing offers, why provision varies so sharply between areas, and how to get more from a referral when one arrives.
In Britain, “therapist” is a job description rather than a protected title, which means the person across the room may hold a doctorate or a six-weekend certificate. This guide explains what BACP, UKCP and HCPC registration actually signify, lists the questions worth asking before you pay a deposit, and sets out the cases in which an NHS route remains the wiser first step.
As winter 2026 draws in, light therapy is often presented as a simple answer to seasonal affective disorder. For many UK households, however, the advice collides with energy costs, patchy NHS access and modest evidence. This explainer sets out what may help, what to ask for, and when low mood needs clinical attention.
A smartwatch can flag an irregular heartbeat or a poor night’s sleep, but it cannot tell you what that means for your health. In 2026, as wearable data becomes more detailed, UK adults need a clearer line between useful self-monitoring and anxious over-reading. This hybrid explainer and opinion piece explores the evidence and offers practical limits.
Self-referring to NHS Talking Therapies can be a sensible first step, but the wait that follows is often uncertain. This AHPP explainer sets out what happens after referral in 2026, why timelines differ by integrated care board, and nine evidence-informed ways to protect your mental health while you wait—without treating self-help as a substitute for care.
Burnout has become shorthand for almost every kind of work-related distress, but the label can obscure what is really happening. This AHPP analysis considers what occupational psychology and GP practice reveal about exhaustion, anxiety, depression and poor job design—and offers a plain-English framework and script for requesting adjustments.